Previous 10 |
SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, reports an increase in strategic partnership, physician and researcher inquiries, and licensing opportunities. The international i...
SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology will receive its first clinical unit prototype and begin testing to verify design parameters. The Nu-Med Plus clinical unit is...
News, Short Squeeze, Breakout and More Instantly...
SALT LAKE CITY, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD ) , a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company has filed a U.S. provisional pa...
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD) , a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (...
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD) , a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trade...